Browsing by Author Shibayama, Hirohiko
Showing results 1 to 1 of 1
| Issue Date | Title | Author(s) |
|---|---|---|
| 5-Feb-2014 | Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on frontline imatinib or nilotinib 300 mg twice daily. | Hughes, Timothy P.; Hochhaus, Andreas; Kantarjian, Hagop M.; Cervantes Requena, F.; Guilhot, François; Niederwieser, Dietger; le Coutre, Philipp D.; Rosti, Gianantonio; Ossenkoppele, Gert J.; Lobo, Clarisse; Shibayama, Hirohiko; Fan, Xiaolin; Menssen, Hans D.; Kemp, Charisse; Larson, Richard A.; Saglio, Giuseppe |